Manufacturing of Recombinant Adeno-Associated Viral Vectors for Clinical Trials

Molecular Therapy - Methods and Clinical Development - United States
doi 10.1038/mtm.2016.2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Recombinant Adeno-Associated Virus Vectors

Japanese Journal of Thrombosis and Hemostasis
1998English

Vascular-Targeted Recombinant Adeno-Associated Viral Vectors for the Treatment of Rare Diseases

Rare Diseases
2016English

Gene Delivery in Renal Tubular Epithelial Cells Using Recombinant Adeno-Associated Viral Vectors

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2003English

Cre Activated and Inactivated Recombinant Adeno-Associated Viral Vectors for Neuronal Anatomical Tracing or Activity Manipulation

2015English

Proteasome Inhibition Is Partially Effective in Attenuating Pre-Existing Immunity Against Recombinant Adeno-Associated Viral Vectors

PLoS ONE
Multidisciplinary
2012English

Biology of Adeno-Associated Viral Vectors in the Central Nervous System

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2014English

Utility of a Recombinant Adeno-Associated Viral Vector Reference Standard

BioProcessing Journal
2002English

High Throughput Production, Screening and Analysis of Adeno-Associated Viral Vectors

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2000English

Adeno-Associated Virus Vectors

Methods in Molecular Biology
GeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy